企業プロフィール
Senseonics 株価・ニュース・カタリスト
- ティッカー:
- SENS
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
8.03 USD (+2.82%)
終値
最終更新: 2026年8月17日
359M USD
時価総額
株価変動の要因
As of Aug 17, 2026, SENS closed up 2.82% at $8.03. No new same-company headline was identified in the current news window.
企業概要
Implantable Glucose Monitoring
Senseonics develops long-term implantable continuous glucose-monitoring systems for people with diabetes. Its technology places a fluorescence-based sensor under the skin rather than relying on frequently replaced transcutaneous sensors.
Eversense 365
Eversense 365 is designed to provide up to one year of continuous glucose data from a single implanted sensor. A removable external transmitter powers the sensor and sends readings and alerts to a mobile application. Senseonics manufactures the system and now directly manages U.S. commercialization. The company is also transitioning more international sales and marketing activities in-house.
今後のカタリスト
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。